The GBM microenvironment, particularly through the release of IL-6 and the expression of PD-L1 and IDO-1, has been shown to induce the formation of regulatory T cells (Tregs) that blunt the anti-tumor T cell response (52, 63–66). Here, IL6 is linked to glioblastoma.